Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study.
Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Jonas S, Sudan D, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Dong G, Lopez PM, Fung J, Junge G; H2304 Study Group. Saliba F, et al. Among authors: beckebaum s. Am J Transplant. 2013 Jul;13(7):1734-45. doi: 10.1111/ajt.12280. Epub 2013 May 28. Am J Transplant. 2013. PMID: 23714399 Free article. Clinical Trial.
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT.
Fischer L, Klempnauer J, Beckebaum S, Metselaar HJ, Neuhaus P, Schemmer P, Settmacher U, Heyne N, Clavien PA, Muehlbacher F, Morard I, Wolters H, Vogel W, Becker T, Sterneck M, Lehner F, Klein C, Kazemier G, Pascher A, Schmidt J, Rauchfuss F, Schnitzbauer A, Nadalin S, Hack M, Ladenburger S, Schlitt HJ. Fischer L, et al. Among authors: beckebaum s. Am J Transplant. 2012 Jul;12(7):1855-65. doi: 10.1111/j.1600-6143.2012.04049.x. Epub 2012 Apr 11. Am J Transplant. 2012. PMID: 22494671 Free article. Clinical Trial.
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.
De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Saliba F, Jonas S, Sudan D, Fung J, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Witte S, Jiang H, Hexham JM, Junge G; H2304 Study Group. De Simone P, et al. Among authors: beckebaum s. Am J Transplant. 2012 Nov;12(11):3008-20. doi: 10.1111/j.1600-6143.2012.04212.x. Epub 2012 Aug 6. Am J Transplant. 2012. PMID: 22882750 Free PMC article. Clinical Trial.
Everolimus with reduced tacrolimus in liver transplantation.
De Simone P, Beckebaum S, Koneru B, Fung J, Saliba F. De Simone P, et al. Among authors: beckebaum s. Am J Transplant. 2013 May;13(5):1373-4. doi: 10.1111/ajt.12215. Epub 2013 Apr 19. Am J Transplant. 2013. PMID: 23601137 Free article. No abstract available.
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis.
Beckebaum S, Herzer K, Bauhofer A, Gelson W, De Simone P, de Man R, Engelmann C, Müllhaupt B, Vionnet J, Salizzoni M, Volpes R, Ercolani G, De Carlis L, Angeli P, Burra P, Dufour JF, Rossi M, Cillo U, Neumann U, Fischer L, Niemann G, Toti L, Tisone G. Beckebaum S, et al. Ann Transplant. 2018 Nov 13;23:789-801. doi: 10.12659/AOT.910176. Ann Transplant. 2018. PMID: 30420590 Free PMC article.
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
Geissler EK, Schnitzbauer AA, Zülke C, Lamby PE, Proneth A, Duvoux C, Burra P, Jauch KW, Rentsch M, Ganten TM, Schmidt J, Settmacher U, Heise M, Rossi G, Cillo U, Kneteman N, Adam R, van Hoek B, Bachellier P, Wolf P, Rostaing L, Bechstein WO, Rizell M, Powell J, Hidalgo E, Gugenheim J, Wolters H, Brockmann J, Roy A, Mutzbauer I, Schlitt A, Beckebaum S, Graeb C, Nadalin S, Valente U, Turrión VS, Jamieson N, Scholz T, Colledan M, Fändrich F, Becker T, Söderdahl G, Chazouillères O, Mäkisalo H, Pageaux GP, Steininger R, Soliman T, de Jong KP, Pirenne J, Margreiter R, Pratschke J, Pinna AD, Hauss J, Schreiber S, Strasser S, Klempnauer J, Troisi RI, Bhoori S, Lerut J, Bilbao I, Klein CG, Königsrainer A, Mirza DF, Otto G, Mazzaferro V, Neuhaus P, Schlitt HJ. Geissler EK, et al. Among authors: beckebaum s. Transplantation. 2016 Jan;100(1):116-25. doi: 10.1097/TP.0000000000000965. Transplantation. 2016. PMID: 26555945 Free PMC article. Clinical Trial.
Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation.
Becker T, Foltys D, Bilbao I, D'Amico D, Colledan M, Bernardos A, Beckebaum S, Isoniemi H, Pirenne J, Jaray J; MARSILEA Study Group. Becker T, et al. Among authors: beckebaum s. Transplantation. 2008 Dec 27;86(12):1689-94. doi: 10.1097/TP.0b013e31818fff64. Transplantation. 2008. PMID: 19104406 Clinical Trial.
Compliance and tolerability of subcutaneous hepatitis B immunoglobulin self-administration in liver transplant patients: a prospective, observational, multicenter study.
Klein CG, Cicinnati V, Schmidt H, Ganten T, Scherer MN, Braun F, Zeuzem S, Wartenberg-Demand A, Niemann G, Schmeidl R, Beckebaum S. Klein CG, et al. Among authors: beckebaum s. Ann Transplant. 2013 Dec 13;18:677-84. doi: 10.12659/AOT.889269. Ann Transplant. 2013. PMID: 24335787 Free article.
155 results